niacinamide has been researched along with Flushing in 8 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Flushing: A transient reddening of the face that may be due to fever, certain drugs, exertion, or stress.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Niacin has established its role in the prevention of coronary artery disease." | 5.34 | Case reports: new onset flushing due to unauthorized substitution of niacin for nicotinamide. ( Bechtel, M; Kademian, M; Zirwas, M, 2007) |
| " However, niacin can cause flushing and niacinamide probably cause thrombocytopenia." | 4.90 | Benefits and harm of niacin and its analog for renal dialysis patients: a systematic review and meta-analysis. ( Feng, L; He, YM; Huo, DM; Liao, YH; Yang, ZH, 2014) |
| " The results suggest that nicotinic acid in a dosage of 16." | 2.74 | Investigation of niacin on parameters of metabolism in a physiologic dose: randomized, double-blind clinical trial with three different dosages. ( Reimann, J; Schön, C; Schweikart, J, 2009) |
| " Since both drugs are extensively metabolized, this study investigated the bioavailability and pharmacokinetics of their co-administration following single-dose administration." | 2.73 | The comparative bioavailability of an extended-release niacin and lovastatin fixed dose combination tablet versus extended-release niacin tablet, lovastatin tablet and a combination of extended-release niacin tablet and lovastatin tablet. ( Cefali, E; Menon, R; Tolbert, D, 2007) |
| "Niacin has been used for decades in the treatment of patients with disturbed lipid and lipoprotein metabolism, this being the main cause of atherosclerotic changes in cardiovascular diseases." | 2.44 | [Niacin in therapy]. ( Bryła, J; Nagalski, A, 2007) |
| "Niacin has established its role in the prevention of coronary artery disease." | 1.34 | Case reports: new onset flushing due to unauthorized substitution of niacin for nicotinamide. ( Bechtel, M; Kademian, M; Zirwas, M, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| He, YM | 1 |
| Feng, L | 1 |
| Huo, DM | 1 |
| Yang, ZH | 1 |
| Liao, YH | 1 |
| Schweikart, J | 1 |
| Reimann, J | 1 |
| Schön, C | 1 |
| Nagalski, A | 1 |
| Bryła, J | 1 |
| Menon, R | 1 |
| Tolbert, D | 1 |
| Cefali, E | 1 |
| Kademian, M | 1 |
| Bechtel, M | 1 |
| Zirwas, M | 1 |
| Subissi, A | 1 |
| Bachi, M | 1 |
| Brunori, P | 1 |
| Dallimore, KJ | 1 |
| Walter, AA | 1 |
2 reviews available for niacinamide and Flushing
| Article | Year |
|---|---|
Benefits and harm of niacin and its analog for renal dialysis patients: a systematic review and meta-analysis.
Topics: Flushing; Humans; Lipoproteins, HDL; Niacin; Niacinamide; Phosphorus; Randomized Controlled Trials a | 2014 |
[Niacin in therapy].
Topics: Adipocytes; Adiponectin; Animals; Cholesterol, HDL; Delayed-Action Preparations; Flushing; Humans; H | 2007 |
2 trials available for niacinamide and Flushing
| Article | Year |
|---|---|
Investigation of niacin on parameters of metabolism in a physiologic dose: randomized, double-blind clinical trial with three different dosages.
Topics: Adult; Blood Pressure; Body Mass Index; Cross-Over Studies; Diet; Dietary Supplements; Double-Blind | 2009 |
The comparative bioavailability of an extended-release niacin and lovastatin fixed dose combination tablet versus extended-release niacin tablet, lovastatin tablet and a combination of extended-release niacin tablet and lovastatin tablet.
Topics: Adult; Aged; Antineoplastic Agents; Area Under Curve; Biological Availability; Cross-Over Studies; D | 2007 |
4 other studies available for niacinamide and Flushing
| Article | Year |
|---|---|
Case reports: new onset flushing due to unauthorized substitution of niacin for nicotinamide.
Topics: Anti-Inflammatory Agents; Drug Prescriptions; Female; Flushing; Humans; Middle Aged; Niacin; Niacina | 2007 |
Some cardiovascular effects of LG 13979: comparison with nicotinic acid and other nicotinic acid derivatives.
Topics: Animals; Blood Pressure; Female; Flushing; Guinea Pigs; Heart Rate; Hemodynamics; Male; Niacin; Niac | 1983 |
Response to the article, 'Pellagra in a woman using alternative remedies'.
Topics: Administration, Oral; Complementary Therapies; Female; Flushing; Humans; Niacin; Niacinamide; Pellag | 1998 |
Megavitamin and megamineral therapy in childhood.
Topics: Flushing; Humans; Hypercholesterolemia; Niacin; Niacinamide | 1992 |